Agilon Health
AGL
209 hedge funds and large institutions have $1.69B invested in Agilon Health in 2024 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 63 increasing their positions, 65 reducing their positions, and 34 closing their positions.
26% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 34
20% more call options, than puts
Call options by funds: $12.2M | Put options by funds: $10.2M
4% more funds holding
Funds holding: 201 → 209 (+8)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.25% less ownership
Funds ownership: 4.43% → 4.19% (-0.25%)
3% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 65
43% less capital invested
Capital invested by funds: $2.98B → $1.69B (-$1.29B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$22.7M |
| 2 |
Citigroup
New York
|
+$10M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$8.62M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$6.27M |
| 5 |
Amundi
Paris,
France
|
+$4.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$148M |
| 2 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$16.5M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$15.3M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.9M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$6.65M |
AGL Hedge Fund Activity: Q3 2024 in Review
209 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q3 2024, worth a combined $1.69B — down 43% from $2.98B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new AGL positions and 34 closed out — a net gain of 9 holders — while 63 added to existing stakes and 65 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $22.7M. The largest seller was Fidelity Investments, cutting an estimated $148M.
- 209 institutional investors held Agilon Health (AGL) as of Q3 2024, up from 201 in Q2 2024.
- Funds reported $1.69B of Agilon Health stock for Q3 2024, down 43% quarter-over-quarter.
- 43 funds opened new Agilon Health positions in Q3 2024 and 34 closed out, a net change of +9 holders.
- The largest Agilon Health buyer in Q3 2024 was Goldman Sachs, an estimated $22.7M added.
- The largest Agilon Health seller in Q3 2024 was Fidelity Investments, an estimated $148M sold.
Based on aggregated 13F filings for Q3 2024.